RNS ANNOUNCEMENT
iShares plc (the "Company")
iShares MSCI Taiwan UCITS ETF (the "Fund") - ISINs: IE000AJFZ9E4/ IE00B0M63623
17 July 2026
The directors of the Company wish to advise you of a change to the securities lending limits for the Fund and its German tax classification metric, as detailed below.
Current New | Expected Net Asset Value subject to securities lending (%) 0 - 10% 0 - 39% | Maximum Net Asset Value subject to securities lending (%) 11% 43% |
The current minimum equity ratio of 80% for German tax purposes is being reduced to 51%. The reduction of the minimum equity ratio allows for additional securities lending flexibility and does not impact the Fund's classification as an equity fund for the purposes of the German Investment Tax Act. This change does not impact on the manner in which the Fund tracks its benchmark index.
These changes are due to take effect on or around 31 July 2026 (the "Effective Date").
A new version of the Company's prospectus will be published on or around the Effective Date.
An electronic copy of the full shareholder letter shall be made available shortly for inspection at https://data.fca.org.uk/#/nsm/nationalstoragemechanism and available to download from the iShares website www.ishares.com
We understand that investors may have questions in relation to this event. If you have any queries, but you do not have a usual iShares contact, you can contact iShares in your respective region on the below contact numbers and email addresses:
• If located in the United Kingdom or if located elsewhere than the below, you can contact iShares at: [email protected], or the helpline telephone number: +44 207 743 1500
• If located in Germany, you can contact iShares at: [email protected], or the helpline telephone number: +49 89 42729 5858
• If located in Switzerland, you can contact iShares at: [email protected], or the helpline telephone number 0800 33 66 88
-END-
This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact [email protected] or visit www.rns.com.RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy. END MSCDZGMNRNGGVZG